GlassScriptPhysician profile
Emily Morgan
NPI 1881233278
$737.50
in general payments reported to CMS, 2019-2025
15 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.51 · 2023: $320 · 2024: $67.06 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $162.74 | 2023-2025 | Fasenra, Breztri, Farxiga |
| Tg Therapeutics, INC. | $124.56 | 2025 | |
| Novo Nordisk INC | $95.19 | 2023 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $64.99 | 2022-2025 | |
| Argenx US, INC. | $62.24 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Takeda Pharmaceuticals U.S.A., INC. | $53.63 | 2023-2025 | Gammagard, Entyvio, Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.58 | 2023-2024 | Spevigo |
| Lilly USA, LLC | $28.66 | 2023 | Jardiance, Emgality, Mounjaro |
| Axsome Therapeutics, INC. | $20.79 | 2023 | Auvelity |
| Exact Sciences Corporation | $16.73 | 2023 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $15.67 | 2023 | Quviviq |
| Shield Therapeutics INC | $14.97 | 2023 | Accrufer |
| Sanofi-Aventis U.S. LLC | $14.38 | 2023 | |
| Pharmacosmos Therapeutics INC. | $13.65 | 2024 | Monoferric |
| Bayer Healthcare Pharmaceuticals INC. | $12.72 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.